Compounds having activity as inhibitors of the JNK pathway are disclosed. The compounds of this invention are anilinopyrimidine derivatives having the following structure: ##STR00001## wherein R.sub.1 through R.sub.6 are as defined herein. Such compounds have utility in the treatment of a wide range of conditions that are responsive to inhibition of the JNK pathway. Thus, methods of treating such conditions are also disclosed, as are pharmaceutical compositions containing one or more compounds of the above compounds.

 
Web www.patentalert.com

< Methods of using non-human animal Apolipoprotein A-I protein

< Nicotinamide biaryl derivatives useful as inhibitors of PDE4 isozymes

> Ricin-like toxins for treatment of cancer

> Autoimmune disease model animal

~ 00299